{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:26:23Z","timestamp":1770888383272,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.arcmed.2007.06.006","type":"journal-article","created":{"date-parts":[[2007,8,4]],"date-time":"2007-08-04T07:11:35Z","timestamp":1186211495000},"page":"858-863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Interleukin-10 Gene Polymorphism in Parkinson's Disease Patients"],"prefix":"10.1016","volume":"38","author":[{"given":"Monika","family":"Bialecka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Klodowska-Duda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Kurzawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Slawek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Opala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Bialecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Safranow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Dro\u017adzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2007.06.006_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1212\/WNL.55.4.533","article-title":"Variability and validity of polymorphism association studies in Parkinson's disease","volume":"55","author":"Tan","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.06.006_bib2","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.arcmed.2007.06.006_bib3","first-page":"277","article-title":"Changes in cytokines and neurotrophins in Parkinson's disease","volume":"60","author":"Nagatsu","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.arcmed.2007.06.006_bib4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson's disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2007.06.006_bib5","first-page":"I35","article-title":"Inflammation in Parkinson's disease","volume":"250","author":"Wullner","year":"2003","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.arcmed.2007.06.006_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1332.007","article-title":"Inflammation and the degenerative diseases of aging","volume":"1035","author":"McGeer","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.arcmed.2007.06.006_bib7","doi-asserted-by":"crossref","unstructured":"Kruger R, Hardt C, Tschentscher F, Jackel S, Kuhn W, Muller T, et\u00a0al. Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. J Neural Transm 200;107:553\u2013562.","DOI":"10.1007\/s007020070078"},{"key":"10.1016\/j.arcmed.2007.06.006_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(00)00991-5","article-title":"Influence of interleukin-1\u03b2 gene polymorphisms on age-at-onset of sporadic Parkinson's disease","volume":"284","author":"Nishimura","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.06.006_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(01)02111-5","article-title":"Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease","volume":"311","author":"Nishimura","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.06.006_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0098-2997(93)90004-W","article-title":"Potential involvement of the transcription factor NF-kappa B in neurological disorders","volume":"14","author":"Kaltschmidt","year":"1993","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.arcmed.2007.06.006_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jnr.10253","article-title":"Cytokines, chemokines, and cytokine receptors in human microglia","volume":"69","author":"Lee","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.arcmed.2007.06.006_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0753-3322(99)80079-1","article-title":"IL-1\u03b2, IL-2, IL-6 and TNF-\u03b1 production by peripheral blood mononuclear cells from patients with Parkinson's disease","volume":"53","author":"Bessler","year":"1999","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.arcmed.2007.06.006_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.gene.6363964","article-title":"Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease","volume":"4","author":"Lio","year":"2003","journal-title":"Genes Immun"},{"key":"10.1016\/j.arcmed.2007.06.006_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neulet.2004.08.016","article-title":"Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease","volume":"370","author":"Huerta","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.06.006_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0304-3940(02)00301-4","article-title":"Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease","volume":"326","author":"Schulte","year":"2002","journal-title":"Neurosc Lett"},{"key":"10.1016\/j.arcmed.2007.06.006_bib16","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1073\/pnas.95.16.9465","article-title":"Interleukin 10 secretion in relation to human IL-10 locus haplotypes","volume":"95","author":"Eskdale","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.06.006_bib17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.510300207","article-title":"Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa","volume":"30","author":"Edwards-Smith","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2007.06.006_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(98)85018-6","article-title":"Haplotype associated with low interleukin-10 production in patients with severe asthma","volume":"352","author":"Lim","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2007.06.006_bib19","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.166.6.3915","article-title":"Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus","volume":"166","author":"Gibson","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2007.06.006_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/1529-0131(200105)44:5<1209::AID-ANR205>3.0.CO;2-S","article-title":"IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients","volume":"44","author":"Kaluza","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcmed.2007.06.006_bib21","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2002-11-3568","article-title":"Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation","volume":"103","author":"Keen","year":"2004","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.arcmed.2007.06.006_bib22","first-page":"165","article-title":"Parkinson's Disease Society Brain Bank, London: overview and research","volume":"39","author":"Daniel","year":"1993","journal-title":"J Neural Transm"},{"key":"10.1016\/j.arcmed.2007.06.006_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression, and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.06.006_bib24","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/hmg\/11.22.2787","article-title":"Functional association of the parkin gene promoter with idiopathic Parkinson's disease","volume":"11","author":"West","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.arcmed.2007.06.006_bib25","first-page":"298","article-title":"A fast method for high-quality genomic DNA extraction from whole human blood","volume":"11","author":"Gustincich","year":"1991","journal-title":"Biotechniques"},{"key":"10.1016\/j.arcmed.2007.06.006_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the interleukin-10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.arcmed.2007.06.006_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1744-313X.2005.00524.x","article-title":"Frequencies of the common promoter polymorphisms in cytokine genes in a Polish population","volume":"32","author":"Kurzawski","year":"2005","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.arcmed.2007.06.006_bib28","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/WNL.56.7.982","article-title":"A polymorphism in the intronic region of the IL-1alpha gene and the risk for Parkinson's disease","volume":"56","author":"Dodel","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.06.006_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0197-0186(95)00138-7","article-title":"IL-10 production by adult human derived microglial cells","volume":"29","author":"Williams","year":"1996","journal-title":"Neurochem Int"},{"key":"10.1016\/j.arcmed.2007.06.006_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/thorax.58.2.154","article-title":"Association of IL-10 polymorphism with severity of illness in community acquired pneumonia","volume":"58","author":"Gallagher","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.arcmed.2007.06.006_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-5728(99)00146-0","article-title":"Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis","volume":"101","author":"Pickard","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.arcmed.2007.06.006_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/jmg.40.4.296","article-title":"Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 \u22121082 promoter SNP and its interaction with TNF-alpha \u2212308 promoter SNP","volume":"40","author":"Lio","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.arcmed.2007.06.006_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2370.2002.00303.x","article-title":"Allele frequencies of polymorphisms of TNFA, IL-6, IL-10 and IFNG in an Italian Caucasian population","volume":"29","author":"Poli","year":"2002","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.arcmed.2007.06.006_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.gene.6363669","article-title":"Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3\u2032 mismatches in forward and reverse primers","volume":"1","author":"Koss","year":"2000","journal-title":"Genes Immun"},{"key":"10.1016\/j.arcmed.2007.06.006_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.gene.6363827","article-title":"Gender-specific association between \u22121082 IL-10 promoter polymorphism and longevity","volume":"3","author":"Lio","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.arcmed.2007.06.006_bib36","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO;2-X","article-title":"A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity","volume":"31","author":"Bonafe","year":"2001","journal-title":"Eur J Immunol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907002068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907002068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:34:41Z","timestamp":1759260881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440907002068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0188440907002068"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.06.006","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-10 Gene Polymorphism in Parkinson's Disease Patients","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}